Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Glioblastoma 3Lymphoma 2Sarcoma 1Recurrence 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Medulloblastoma 1Leukemia 1Gliosarcoma 1Glioma 1Carcinoma 1Astrocytoma 1

Interventions

Automobiles 3fludarabine 2Sirolimus 2Granulocyte Colony-Stimulating Factor 2Gemcitabine 2Cyclophosphamide 2trametinib 1sonidegib 1ripretinib 1ribociclib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1keyhole-limpet hemocyanin 1interferon gamma-1b 1guadecitabine 1fludarabine phosphate 1Vorinostat 1Topotecan 1Tetrahydrouridine 1Tetanus Toxoid 1Stem Cell Transplantation 1Simvastatin 1Photochemotherapy 1Oncolytic Virotherapy 1Mesna 1Melphalan 1Interferon-gamma 1Immunotherapy 1Filgrastim 1Dihematoporphyrin Ether 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms, Germ Cell and Embryonal × Tetanus Toxoid × Clear all
NCT00369291 2017-11-29

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
19 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, Germ Cell and Embryonal, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡